Hebo Biotechnology Completes C Round of Financing

Hebo Biotechnology Co., Ltd. announced that it has completed a series C financing of more than 100 million yuan. This round of investment by SDIC will help the industrialization of liquid-phase microfluidic biochip products, accelerate the development of microfluidic iterative products, and promote the company Marketing channel construction and overseas network construction.

Founded in 2006, Hebo Bio is a technology-based enterprise focusing on IVD technology innovation. For 14 years, it has been based on technology, grasping the cutting edge, insisting on originality, and has 154 patents and 48 EU CE certifications; it has built a multi-methodological integrated immunity Analysis system, triple quality control system, cloud big data platform, products covering nearly 10,000 terminals in 60 countries.

Hipro biotechnology Corp, founded on September 29th, 2006, is a high-tech enterprise based on international advanced medical technologies and brilliant self-innovations to provide first class products all over the world. Hipro focuses on R&D, manufacturing, marketing, and relevant services of Point-of Care products. Hipro, with her  reagent R&D Center at Silicon Valley,USA and instrument R&D Center at Freiburg,Germany and production base in China - Hebei Province, has established branches in San Francisco, Freiburg， Beijing, Suzhou, Chengdu, Guangzhou etc., and launched 3.69 acres industrial park project in China Medical City.

Hipro has a world-class high capacity manufacturing facility （10000 sq.m.） with 1500 sq.m. current GMP  plants and strict quality control system. The quality system is NGSP, ISO 13485 and CE certified by TUV Rheinland.

Hipro is a leading specialist in the development and manufacturing of diagnostic system solutions of highest quality, trusted by customers all over the world for over 19 years. The product portfolio comprises more than 40 parameters including Biochemistry, Nephelometry,Fluorescence and Turbidimetric reagents for routine and special diagnostics including the third party calibrators and controls. The Hipro instrumentation product range covers automated immunoassay analyzers, semi-automated analyzers and other POC instruments for patient-near testing.

The sales network covers the whole Chinese mainland, and throughout more than 40 countries : Switzerland , Netherlands , Germany ,Austria , Greece , Iraq , Jordan , Lebanon , India , Indonesia , Egypt...

Hipro’s competitiveness rooted in the first-class products, self-innovated key technologies, acute sense for cutting edge technology, excellent management team, and strict quality control sytem.

Hipro adheres to her core values of simplicity, integrity, diligence, and excellent Hipro’s continuous strive for a better design that ensures the user a simpler operational experience, faster and accurate test result, and better service, makes her a leading figure in the healthcare field.